Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Cogent Biosciences
.
Show all posts
Showing posts with label
Cogent Biosciences
.
Show all posts
Monday, September 7, 2026
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
›
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
›
Home
View web version
